Prof. Dr. Ulrike Bingel (Project Leader A11) studies the interplay between pain processing in the central nervous system and cognitive processes. A key challenge in her research is the question of why acute pain becomes chronic in some people while others recover – and how personalized treatment strategies can address these different outcomes.
Bingel places particular emphasis on placebo and nocebo effects, which are based on measurable neurobiological and physiological mechanisms and do not play a role only in placebo treatments. Expectations can improve the efficacy and tolerability of medical interventions, but they can also exacerbate symptoms and side effects – for Bingel, placebo effects are therefore not merely a challenge for clinical trials, but rather a therapeutic resource.
As the spokesperson for the DFG-funded SFB/TRR 289 “Treatment Expectation,” Bingel combines basic research with the development of personalized treatment approaches. The Erwin L. Hahn Institute offers unique opportunities to investigate the neural mechanisms of pain and expectation using high-resolution imaging.
